4768:TSEOTSUKA CORPORATION Analysis
Data as of 2026-06-12 - not real-time
₩92,300.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Rznomics is trading at 92,300 KRW, well below its 20‑day (121,225), 50‑day (160,056) and 200‑day (161,732) simple moving averages, signaling a strong bearish momentum. The MACD line sits beneath its signal line with a negative histogram, and the RSI is at 27, indicating the stock is oversold but still in a downtrend. Volume is decreasing, and the 30‑day volatility is a lofty 87%, while a beta of 1.5 points to amplified market swings. The price sits near the identified support of 83,000 KRW and far from the resistance at 157,600 KRW, with a historical max drawdown of nearly 63%. Technical indicators suggest limited short‑term upside, yet the extreme‑greed market sentiment may tempt speculative buying. Fundamentally, the company reports zero revenue and earnings, offering no traditional valuation anchors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish trend with price below all major moving averages
- Decreasing volume and negative MACD histogram
- Price approaching immediate support level
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Oversold RSI suggesting potential rebound
- Potential catalyst from upcoming Phase 1/2 trial results
- Extreme‑greed market sentiment may provide buying pressure
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High growth potential of RNA‑based gene therapies
- Long‑term upside in biotechnology sector despite current lack of revenue
- Strategic positioning in multiple high‑need disease areas
Key Metrics & Analysis
Financial Health
Industry P/E24.9
Technical Analysis
TrendBearish
RSI27.2
Support₩83,000.00
Resistance₩157,600.00
MA 20₩121,225.00
MA 50₩160,056.00
MA 200₩161,732.17
MACDBearish
VolumeDecreasing
Fear & Greed Index87.07
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.50
Volatility87.10%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.